14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
CAMP vs DGII: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Digi International Inc (DGII) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CAMP carries a Unified Composite Score of 41.9/100 (SELL) at $3.95 (N/M Forward P/E, -991.8% operating margin), whereas DGII carries 41.1/100 (SELL) at $53.16 (15.1x Forward P/E, 14.9% operating margin).
Composite vs. Pillar Nuance: While CAMP currently prints a higher short-term Unified Composite Score (41.9/100 SELL vs. DGII 41.1/100 SELL), DGII captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (14.9% vs. -991.8% operating margin) and revenue trajectory (+25.3% vs. +138.9% YoY).
Defensive Composite Rating Caution: Although DGII compares more favorably head-to-head, both CAMP (41.9/100 SELL) and DGII (41.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 53.3); meanwhile DGII is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Communication Equipment value chain with $2.1B market capitalization and 14.9% operating margin.
OpEx & R&D Reinvestment48.9% of Rev ($262M)
90D Engineering Disclosures0 Published
Investor FAQ CAMP vs DGII Key Questions & Quantitative Answers
As of Nov 17, 2026, Digi International Inc (DGII) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CAMP carries a Unified Composite Score of 41.9/100 (SELL) at $3.95 (N/M Forward P/E, -991.8% operating margin), whereas DGII carries 41.1/100 (SELL) at $53.16 (15.1x Forward P/E, 14.9% operating margin). Composite vs. Pillar Nuance: While CAMP currently prints a higher short-term Unified Composite Score (41.9/100 SELL vs. DGII 41.1/100 SELL), DGII captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (14.9% vs. -991.8% operating margin) and revenue trajectory (+25.3% vs. +138.9% YoY). Defensive Composite Rating Caution: Although DGII compares more favorably head-to-head, both CAMP (41.9/100 SELL) and DGII (41.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 53.3); meanwhile DGII is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
DGII leads the Growth & Scale pillar: CAMP posts +138.9% YoY revenue growth and +0.0% YoY earnings growth on $5.3M TTM revenue (N/A gross margin, -991.8% operating margin), compared with DGII at +25.3% YoY revenue growth and +45.6% YoY earnings growth on $535M TTM revenue (63.8% gross margin, 14.9% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CAMP cumulative revenue shifted N/A while DGII shifted +87.0%. In operating R&D and SG&A reinvestment, CAMP deploys N/A (0 90-day corporate R&D disclosures) versus 48.9% of Rev ($262M) (0 disclosures) for DGII.
DGII screens cheaper on headline valuation multiples. CAMP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 26.6x EV/Revenue (unreported FCF margin), whereas DGII trades at 15.1x Forward P/E, 40.2x Trailing P/E, 0.83x PEG, and 3.9x EV/Revenue (23.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CAMP (-146.1% ROE) versus DGII (8.0% ROE) capital efficiency.
In options market volatility and institutional positioning, CAMP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.34β · 94% Vol realized risk). By comparison, DGII carries 50.6% implied volatility (9th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.94β · 78% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.